The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{3-fluoro-5-[(S-methylsulfonodiimidoyl)methyl]phenyl}pyrimidin-2-amine ID: ALA4762845
Cas Number: 1610408-97-3
PubChem CID: 139593425
Product Number: E610134, Order Now?
Max Phase: Preclinical
Molecular Formula: C19H18F2N4O2S
Molecular Weight: 404.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(F)ccc1-c1cc(Nc2cc(C[S@@](C)(=N)=O)ccn2)ncc1F
Standard InChI: InChI=1S/C19H18F2N4O2S/c1-27-17-8-13(20)3-4-14(17)15-9-19(24-10-16(15)21)25-18-7-12(5-6-23-18)11-28(2,22)26/h3-10,22H,11H2,1-2H3,(H,23,24,25)/t28-/m0/s1
Standard InChI Key: YZCUMZWULWOUMD-NDEPHWFRSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
14.5343 -10.6007 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9510 -11.3174 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.3633 -10.5982 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2409 -10.4965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2396 -11.3239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9546 -11.7368 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6710 -11.3234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6682 -10.4929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9527 -10.0837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9474 -9.2614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6623 -8.8474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6603 -8.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9440 -7.6119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2283 -8.0310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2340 -8.8540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9404 -6.7869 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.3777 -9.2585 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0914 -8.8447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3862 -11.7348 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1001 -11.3212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8119 -11.7330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5253 -11.3201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5244 -10.4941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8042 -10.0829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0937 -10.4982 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2402 -11.7318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6692 -11.7303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5262 -10.0841 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
9 10 1 0
13 16 1 0
11 17 1 0
17 18 1 0
7 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
22 26 1 0
2 26 1 6
2 27 1 0
4 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.44Molecular Weight (Monoisotopic): 404.1119AlogP: 4.35#Rotatable Bonds: 6Polar Surface Area: 87.96Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.52CX Basic pKa: 4.46CX LogP: 2.56CX LogD: 2.56Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -0.93
References 1. Mäder P,Kattner L. (2020) Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry., 63 (23.0): [PMID:32870008 ] [10.1021/acs.jmedchem.0c00960 ]